4.5 Review

The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis

Related references

Note: Only part of the references are listed.
Article Medical Laboratory Technology

Assessment of tryptophan and kynurenine as prognostic markers in patients with SARS-CoV-2

Simon Michaelis et al.

Summary: Measuring the concentrations of tryptophan and kynurenine upon admission, as well as calculating the KYN/TRP ratio, can predict the survival outcome of patients with SARS-CoV-2.

CLINICA CHIMICA ACTA (2022)

Article Clinical Neurology

Intersections between pneumonia, lowered oxygen saturation percentage and immune activation mediate depression, anxiety, and chronic fatigue syndrome-like symptoms due to COVID-19: A nomothetic network approach

Hawraa Kadhem Al-Jassas et al.

Summary: This study aims to investigate the associations between affective and chronic fatigue syndrome-like symptoms and chest CT scan anomalies, oxygen saturation, inflammatory biomarkers, etc. in COVID-19 patients. The results showed that the immune response core was associated with lung lesions and affective and physiosomatic symptoms. The infection-immune-inflammatory core plays a significant role in pneumonia-associated CT scan anomalies, decreased oxygen saturation, and immune activation, and it affects the affective and neuropsychiatric symptoms of patients.

JOURNAL OF AFFECTIVE DISORDERS (2022)

Review Biochemistry & Molecular Biology

Inflammation and nitro-oxidative stress in current suicidal attempts and current suicidal ideation: a systematic review and meta-analysis

Asara Vasupanrajit et al.

Summary: Recent studies have shown a significant association between activated immune-inflammatory and nitro-oxidative pathways and suicide attempts. Inflammation, immune activation, nitro-oxidative stress, lowered neuroprotection, and increased neurotoxicity may explain why psychiatric patients exhibit increased suicidal behaviors.

MOLECULAR PSYCHIATRY (2022)

Review Pharmacology & Pharmacy

Immunopathogenesis and Immunogenetic Variants in COVID-19

Pakorn Sagulkoo et al.

Summary: This study reviews the immunopathogenesis and immunogenetic variants of COVID-19, proposing potential therapeutic targets and preventive strategies, providing important insights for predicting and treating severe COVID-19.

CURRENT PHARMACEUTICAL DESIGN (2022)

Editorial Material Chemistry, Medicinal

The Tryptophan Catabolite or Kynurenine Pathway's Role in Major Depression

Abbas F. Almulla et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2022)

Review Biochemistry & Molecular Biology

The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments

Abbas F. Almulla et al.

Summary: The tryptophan catabolite (TRYCAT) pathway is involved in the pathophysiology of schizophrenia through the activation of the enzyme indoleamine-dioxygenase (IDO) by inflammatory and oxidative stress mediators. This systematic review examined the association between TRYCATs in the central nervous system (CNS) and peripheral blood in schizophrenia patients. The findings showed significant differences in TRYCAT levels between the CNS and peripheral blood, with only a modest increase in serum IDO activity associated with CNS findings.

MOLECULAR PSYCHIATRY (2022)

Review Neurosciences

The Tryptophan Catabolite or Kynurenine Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis

Abbas F. Almulla et al.

Summary: This study aimed to investigate the activity of the TRYCAT pathway and the levels of TRP and TRYCATs in AD patients. The results showed a significant decrease in TRP in AD patients, while the overactivity of the TRYCAT pathway was not a key factor in the pathophysiology of AD.

JOURNAL OF ALZHEIMERS DISEASE (2022)

Review Medicine, General & Internal

Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis

Rubina Mulchandani et al.

Summary: Studies have shown significantly elevated levels of pro-inflammatory cytokines and reduced T lymphocytes in severe COVID-19 cases. However, there is heterogeneity across studies due to small sample sizes, nonuniform outcome assessment, and varied definitions of disease severity, indicating a need for well-designed and adequately powered prospective studies for more definitive answers.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Endocrinology & Metabolism

Association of serum kynurenine/tryptophan ratio with poor glycemic control in patients with type2 diabetes

Sara Abedi et al.

Summary: The study found that T2DM patients had higher levels of FBS, HbA1c, HOMA-IR, and KTR compared to controls, while TAC and HOMA-B were significantly lower. KTR was significantly correlated with HbA1c levels, and T2DM patients with poor glycemic control had higher KTR levels. HOMA-B was significantly correlated with serum tryptophan and inversely correlated with HbA1c.

JOURNAL OF DIABETES AND METABOLIC DISORDERS (2021)

Review Clinical Neurology

Suicide attempts are associated with activated immune-inflammatory, nitro-oxidative, and neurotoxic pathways: A systematic review and meta-analysis

Asara Vasupanrajit et al.

Summary: This meta-analysis identified increased immune activation, inflammation, neurotoxicity, and decreased neuroprotection in patients with suicide attempts compared to healthy controls and patients with fewer suicide attempts.

JOURNAL OF AFFECTIVE DISORDERS (2021)

Review Geriatrics & Gerontology

Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review and meta-analysis

Timotius Ivan Hariyanto et al.

Summary: This study revealed a clear link between dementia patients and poor outcomes of COVID-19 infection, suggesting the importance of providing extra care and close monitoring to minimize the risk of infections and prevent severe and fatal outcomes.

ARCHIVES OF GERONTOLOGY AND GERIATRICS (2021)

Article Biochemistry & Molecular Biology

Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort study

Luana Lionetto et al.

Summary: The study revealed that the Kyn:Trp ratio significantly increases in patients infected with SARS-CoV2, and is associated with the severity of infection and lymphopenia. This suggests that the Kyn:Trp ratio may serve as a valuable biomarker for therapeutic intervention.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Editorial Material Cardiac & Cardiovascular Systems

The emerging role of oxidative stress in complications of COVID-19 and potential therapeutic approach to diminish oxidative stress

Md Mohiuddin et al.

RESPIRATORY MEDICINE (2021)

Review Medical Laboratory Technology

COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?

Michael J. Ombrello et al.

Summary: Cytokine storms, characterized by hyperinflammation, hemodynamic instability, and multiple organ dysfunction, have been observed in conditions like COVID-19 and rheumatic diseases. Treatment often involves corticosteroids and cytokine inhibitors.

TRANSLATIONAL RESEARCH (2021)

Article Multidisciplinary Sciences

Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications

Nan Xiao et al.

Summary: Metabolomic data and cytokine/chemokine profiling from stratified COVID-19 patients suggest a correlation between arginine, tryptophan, and purine metabolic pathways with hyperinflammation, potentially offering therapeutic targets for severe COVID-19 patients. Modulating metabolism can significantly impact the release of proinflammatory cytokines by peripheral blood mononuclear cells, indicating a potential strategy for treating fatal cytokine release syndrome in COVID-19.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients

Judith Marin-Corral et al.

Summary: Analysis of metabolic pathways in COVID-19 patients revealed associations with disease severity. Factors such as obesity, respiratory rate, and blood pressure were linked to severity, while changes in ceramide metabolism and tryptophan degradation correlated with inflammation. The metabolomic profile could potentially aid in stratifying disease severity and guiding clinical decisions.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Increased Kynurenine Indicates a Fatal Course of COVID-19

Harald Mangge et al.

Summary: Kynurenine is a promising blood biomarker for predicting mortality risk in severe COVID-19 cases, with KYN levels at the time of SARS-CoV-2 diagnosis serving as an early indicator of poor outcomes. Age, KYN, ferritin, and other markers were found to significantly impact survival time, underscoring the potential of Kynurenine as a prognostic tool in COVID-19 management.

ANTIOXIDANTS (2021)

Article Microbiology

Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis

Laura Ansone et al.

Summary: The study identified distinct metabolomic profiles in serum samples of COVID-19 patients at different disease stages, indicating the potential roles of tryptophan and arginine metabolism in the immune response to SARS-CoV-2. Additionally, the study suggests that glutamine deprivation may affect immune responses, and highlights the involvement of phenylalanine and tyrosine in the molecular mechanisms underlying severe COVID-19 infection. This research provides functional metabolic markers for disease progression and outcome prediction, suggesting metabolomic profiling as a promising method for personalized care strategies in COVID-19 patients.

MICROBIOLOGY SPECTRUM (2021)

Article Biochemical Research Methods

Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses

Nathan G. Lawler et al.

Summary: SARS-CoV-2 infection is associated with a unique metabolic phenotype, with significant perturbations in amino acid and kynurenine metabolic pathways, possibly leading to neurotoxicity, neurological disruption, and liver dysfunction. Additionally, there is a strong immunometabolic disorder in response to SARS-CoV-2 infection, as evidenced by correlations between key metabolite changes and concentrations of proinflammatory cytokines and chemokines.

JOURNAL OF PROTEOME RESEARCH (2021)

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Medicine, General & Internal

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The article introduces PRISMA 2020, an updated reporting guideline for systematic reviews and meta-analyses.

PLOS MEDICINE (2021)

Article Multidisciplinary Sciences

Immunometabolic signatures predict risk of progression to sepsis in COVID-19

Ana Sofia Herrera-Van Oostdam et al.

Summary: The term viral sepsis accurately describes the multisystem dysregulation in COVID-19 patients. Metabolomic and cytokine analyses revealed distinct metabolic and inflammation patterns between mild and critically ill patients, leading to the development of powerful models for diagnosis, prognosis, and mortality prediction of COVID-19 induced sepsis.

PLOS ONE (2021)

Article Biochemistry & Molecular Biology

Kynurenic acid may underlie sex-specific immune responses to COVID-19

Yuping Cai et al.

Summary: This study reveals a specific link between the serum metabolomes and immune responses in male COVID-19 patients, with the metabolite kynurenic acid (KA) playing a key role in influencing clinical outcomes and immune responses in a sex-specific manner.

SCIENCE SIGNALING (2021)

Editorial Material Psychiatry

False Dogmas in Schizophrenia Research: Toward the Reification of Pathway Phenotypes and Pathway Classes

Michael Maes et al.

FRONTIERS IN PSYCHIATRY (2021)

Article Multidisciplinary Sciences

Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection

Paulo D'Amora et al.

Summary: This study investigated the association between host metabolic signatures and COVID-19 infection, finding that changes in specific metabolite concentrations could serve as predictors of disease severity and mortality. By analyzing metabolic profiles, individuals at higher risk of developing severe complications from COVID-19 infection could be identified, aiding in prognosis, risk stratification, and clinical management. Metabolic factors measured through plasma-based biochemical signatures may play a crucial role in determining the severity of Covid-19 and its implications for patient outcomes.

PLOS ONE (2021)

Article Biochemistry & Molecular Biology

Oxidative stress index can be a new marker related to disease severity in COVID-19

Serdar Dogan et al.

Summary: This study evaluated the relationship between systemic oxidative balance and disease severity in COVID-19 patients, finding that TOS and OSI levels were positively correlated with disease severity, serving as potential markers for assessing disease severity and managing patients with COVID-19.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI (2021)

Article Immunology

Inflammasome activation at the crux of severe COVID-19

Setu M. Vora et al.

Summary: This article provides an update on the role of inflammasomes in SARS-CoV-2 infection and COVID-19, discussing their activation and contribution to the overactive inflammatory response in severe cases. Efforts are being made to target inflammasomes therapeutically. Severe COVID-19 is characterized by dysregulated cytokine release, pneumonia, and acute respiratory distress syndrome, with ongoing clinical efforts to suppress inflammation for prevention and treatment.

NATURE REVIEWS IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

The signal pathways and treatment of cytokine storm in COVID-19

Lan Yang et al.

Summary: The COVID-19 pandemic is a global crisis with devastating effects, where immunopathology plays a crucial role in disease progression, particularly the cytokine storm which has a significant impact on prognosis. Understanding and targeting the pathways involved in cytokine storm could lead to more effective treatment strategies for COVID-19.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Psychiatry

6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records

Maxime Taquet et al.

Summary: Our study provides evidence of significant neurological and psychiatric morbidity in the 6 months following COVID-19 infection. The risks were highest in patients with severe COVID-19. This information could assist in service planning and research priority identification.

LANCET PSYCHIATRY (2021)

Article Multidisciplinary Sciences

Immunometabolic signatures predict risk of progression to sepsis in COVID-19

Ana Sofia Herrera-Van Oostdam et al.

Summary: Viral sepsis is proposed as a term for describing systemic dysregulations in severe COVID-19 cases. Analysis of metabolites and cytokines in patients revealed unique dysregulation patterns, providing powerful models for diagnosis, prognosis, and mortality prediction.

PLOS ONE (2021)

Review Immunology

Peripheral immune aberrations in fibromyalgia: A systematic review, meta-analysis and meta-regression

Laura Andres-Rodriguez et al.

BRAIN BEHAVIOR AND IMMUNITY (2020)

Review Geriatrics & Gerontology

The multiple faces of tryptophan in bone biology

Ahmed Al Saedi et al.

EXPERIMENTAL GERONTOLOGY (2020)

Article Biochemistry & Molecular Biology

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Daniel Blanco-Melo et al.

Article Biochemistry & Molecular Biology

Proteomic and Metabolomic Characterization of COVID-19 Patient Sera

Bo Shen et al.

Review Immunology

The COVID-19 Cytokine Storm; What We Know So Far

Dina Ragab et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Virology

Interleukin-6 in Covid-19: A systematic review andmeta-analysis

Eric A. Coomes et al.

REVIEWS IN MEDICAL VIROLOGY (2020)

Article Infectious Diseases

Serum neopterin levels in relation to mild and severe COVID-19

Josefina Robertson et al.

BMC INFECTIOUS DISEASES (2020)

Article Immunology

What Can Cellular Redox, Iron, and Reactive Oxygen Species Suggest About the Mechanisms and Potential Therapy of COVID-19?

Barry B. Muhoberac

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Article Biochemistry & Molecular Biology

Kynurenine Promotes RANKL-Induced Osteoclastogenesis In Vitro by Activating the Aryl Hydrocarbon Receptor Pathway

Nada H. Eisa et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Hematology

COVID-19 and Respiratory System Disorders Current Knowledge, Future Clinical and Translational Research Questions

Shari B. Brosnahan et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Review Immunology

How COVID-19 induces cytokine storm with high mortality

Shintaro Hojyo et al.

INFLAMMATION AND REGENERATION (2020)

Article Medicine, Research & Experimental

Dysregulation of Tryptophan Catabolism in Metabolic Syndrome

Neila Hiraishi Mallmann et al.

METABOLIC SYNDROME AND RELATED DISORDERS (2018)

Article Biochemistry & Molecular Biology

Free-radical scavenging by tryptophan and its metabolites through electron transfer based processes

Adriana Perez-Gonzalez et al.

JOURNAL OF MOLECULAR MODELING (2015)

Article Health Care Sciences & Services

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

Xiang Wan et al.

BMC MEDICAL RESEARCH METHODOLOGY (2014)

Article Biochemistry & Molecular Biology

Disturbed Tryptophan Metabolism in Cardiovascular Disease

H. Mangge et al.

CURRENT MEDICINAL CHEMISTRY (2014)

Article Biochemistry & Molecular Biology

Activation of the Kynurenine Pathway in the Acute Phase of Stroke and its Role in Fatigue and Depression Following Stroke

Heidi Ormstad et al.

JOURNAL OF MOLECULAR NEUROSCIENCE (2014)

Review Cell Biology

Kynurenines with Neuroactive and Redox Properties: Relevance to Aging and Brain Diseases

Jazmin Reyes Ocampo et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)

Article Immunology

AhR-mediated, non-genomic modulation of IDO1 function

Maria Teresa Pallotta et al.

FRONTIERS IN IMMUNOLOGY (2014)

Review Cell Biology

Quinolinic Acid: An Endogenous Neurotoxin with Multiple Targets

Rafael Lugo-Huitron et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)

Review Clinical Neurology

The kynurenine system and immunoregulation

Yvette Mandi et al.

JOURNAL OF NEURAL TRANSMISSION (2012)

Article Medicine, Research & Experimental

Kynurenine and its metabolites in Alzheimer's disease patients

E. Gulaj et al.

ADVANCES IN MEDICAL SCIENCES (2010)

Article Biochemistry & Molecular Biology

The Role of Tryptophan Catabolism along the Kynurenine Pathway in Acute Ischemic Stroke

Raf Brouns et al.

NEUROCHEMICAL RESEARCH (2010)

Article Immunology

Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase

Silvia K. Schmidt et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2009)

Article Immunology

IDO: A double-edged sword for TH1/TH2 regulation

Hui Xu et al.

IMMUNOLOGY LETTERS (2008)

Article Neurosciences

Characterization of the kynurenine pathway in human neurons

Gilles J. Guillemin et al.

JOURNAL OF NEUROSCIENCE (2007)

Article Biochemistry & Molecular Biology

T cell apoptosis by tryptophan catabolism

I Fallarino et al.

CELL DEATH AND DIFFERENTIATION (2002)

Article Neurosciences

Quinolinic acid induces oxidative stress in rat brain synaptosomes

A Santamaría et al.

NEUROREPORT (2001)